Filter
573
Text search:
National
Tuberculosis
Center
Featured
Recommendations
59
New Publications
157
Language
Document type
No document type
341
Studies & Reports
106
Guidelines
74
Manuals
24
Strategic & Response Plan
13
Training Material
6
Fact sheets
4
Situation Updates
3
App
1
Resource Platforms
1
Countries / Regions
India
25
Rwanda
23
Kenya
20
Ethiopia
15
Nepal
14
Global
14
Liberia
13
Malawi
13
Philippines
10
Uganda
9
Ukraine
9
Latin America and the Carribbean
9
Cambodia
8
Lesotho
8
Sierra Leone
7
Tanzania
7
Bangladesh
7
Nigeria
6
Western and Central Europe
6
Africa
6
Eastern Europe
6
Zambia
5
Namibia
5
Asia
5
Russia
5
Indonesia
4
South Africa
4
Mozambique
4
Guinea
3
Senegal
3
Cameroon
3
Ghana
3
Zimbabwe
3
Syria
3
Benin
3
Colombia
3
South–East Asia Region
3
Tajikistan
3
Georgia
3
Haiti
2
South Sudan
2
Afghanistan
2
Ecuador
2
East and Southern Africa
2
Venezuela
2
Congo, Democratic Republic of
1
Mali
1
Pakistan
1
Jordan
1
Germany
1
Chad
1
Thailand
1
Argentina
1
Peru
1
Honduras
1
Botswana
1
Bolivia
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Albania
1
Armenia
1
Timor Leste/ East Timor
1
Estonia
1
Moldova
1
Vietnam
1
Gabon
1
Turkmenistan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
226
Clinical Guidelines
50
Public Health
24
Women & Child Health
21
Key Resources
20
Pharmacy & Technologies
9
Capacity Building
3
Toolboxes
HIV
104
TB
83
AMR
30
COVID-19
29
NTDs
16
Pharmacy
15
Mental Health
13
Caregiver
13
Health Financing Toolbox
13
Rapid Response
10
Planetary Health
10
Global Health Education
9
Ebola & Marburg
8
Refugee
8
Disability
7
NCDs
7
2.0 Rapid Response
7
Conflict
6
Natural Hazards
5
Polio
2
Malaria
2
Cholera
1
Specific Hazards
1
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
AIDSTAR-One | CASE STUDY SERIES November 2012
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and
...
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
Technical Brief
This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sites.
